Literature DB >> 16932388

Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases.

Vicente E Torres1, Peter C Harris.   

Abstract

Autosomal dominant polycystic kidney disease and autosomal recessive polycystic kidney disease are the best known of a large family of inherited diseases characterized by the development of renal cysts of tubular epithelial cell origin. Autosomal dominant and recessive polycystic kidney diseases have overlapping but distinct pathogeneses. Identification of the causative mutated genes and elucidation of the function of their encoded proteins is shedding new light on the mechanisms that underlie tubular epithelial cell differentiation. This review summarizes recent literature on the role of primary cilia, intracellular calcium homeostasis, and signaling involving Wnt, cyclic AMP and Ras/MAPK, in the pathogenesis of polycystic kidney disease. Improved understanding of pathogenesis and the availability of animal models orthologous to the human diseases provide an excellent opportunity for the development of pathophysiology-based therapies. Some of these have proven effective in preclinical studies, and clinical trials have begun.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932388     DOI: 10.1038/ncpneph0070

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  131 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

2.  Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics.

Authors:  Jason D Hoffert; Trairak Pisitkun; Fahad Saeed; Jae H Song; Chung-Lin Chou; Mark A Knepper
Journal:  Mol Cell Proteomics       Date:  2011-11-21       Impact factor: 5.911

3.  Primary cilia regulates the directional migration and barrier integrity of endothelial cells through the modulation of hsp27 dependent actin cytoskeletal organization.

Authors:  Thomas J Jones; Ravi K Adapala; Werner J Geldenhuys; Chris Bursley; Wissam A AbouAlaiwi; Surya M Nauli; Charles K Thodeti
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

4.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

5.  Calcimimetic inhibits late-stage cyst growth in ADPKD.

Authors:  Vincent H Gattone; Neal X Chen; Rachel M Sinders; Mark F Seifert; Danxia Duan; David Martin; Charles Henley; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

6.  Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial.

Authors:  Osama W Amro; Jessica K Paulus; Farzad Noubary; Ronald D Perrone
Journal:  Am J Kidney Dis       Date:  2016-09-20       Impact factor: 8.860

7.  Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+]i homeostasis in human autosomal-dominant polycystic kidney disease cells.

Authors:  Viktor Tomilin; Gail A Reif; Oleg Zaika; Darren P Wallace; Oleh Pochynyuk
Journal:  FASEB J       Date:  2018-03-19       Impact factor: 5.191

8.  Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD.

Authors:  Trairak Pisitkun; Vinitha Jacob; Stephen M Schleicher; Chung-Lin Chou; Ming-Jiun Yu; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

9.  Loss of polycystin-1 causes centrosome amplification and genomic instability.

Authors:  Lorenzo Battini; Salvador Macip; Elena Fedorova; Steven Dikman; Stefan Somlo; Cristina Montagna; G Luca Gusella
Journal:  Hum Mol Genet       Date:  2008-06-19       Impact factor: 6.150

10.  Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.

Authors:  Monalisa N Muchatuta; Vincent H Gattone; Frank A Witzmann; Bonnie L Blazer-Yost
Journal:  Exp Biol Med (Maywood)       Date:  2008-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.